Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has repurchased an aggregate of roughly CA$12.3 million ($9 million) principal amount of its convertible senior notes in multiple transactions between August 16 and September 8, 2023.

What Happened

A total cash cost of CA$12.3 million, including accrued interest, was satisfied by issuing an aggregate of approximately 20.1 million common shares of Aurora, the Edmonton, Alberta-based company said on Friday.

The news comes on the heels of the Department of Health and Human Services’ call to the DEA to reclassify cannabis from a Schedule I to III under the Controlled Substances Act.

Why It Matters

The Canadian cannabis giant said that the transactions will reduce its debt and annual cash interest costs while helping it achieve positive free cash flow in 2024.

Additionally, the move would save Aurora CA$660 000 in annualized …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.